GEN Exclusives

More »

GEN News Highlights

More »
Oct 27, 2009

CLC bio to Provide Next-Generation Sequencing Solutions in Japan Through Filgen

  • CLC bio is expanding the distribution of its next-generation sequencing solutions into the Japanese market through a deal with Filgen. “In 2009, we have experienced a considerable increase of interest in our solutions from Japan,” according to director of partner sales at CLC bio, Michael Heltzen.

    “This is logically linked with the significant increase of next-generation sequencing instruments being installed, which in turn requires analysis capacity of the huge amounts of data, an area where we excel. We regard the Japanese life science sector as one of the premier markets in Asia and are happy to announce this setup, so we can support our current and upcoming customers in Japan in the best possible way.”

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »